10 results
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
known or suspected malignant ... pleural effusion ... Official ATS/STS/STR Clinical ... goals of assessing lung ... #Algorithm #Management
Fibrinous septations in Malignant Pleural Effusion (MPE) - Lung POCUS
 • can be triggered by thoracenteses
Pleural Effusion ... (MPE) - Lung POCUS ... prospective e/o dyspnea ... #clinical #ultrasound ... #pulmonary
Empyema on POCUS

89-year-old male with fever and dyspnea. Lung ultrasound reveals what chest x-ray hides -
with fever and dyspnea ... Lung ultrasound ... Loculated Pleural Effusion ... #Ultrasound #POCUS ... #Clinical #Pulmonary
Large complex pleural effusion on Lung POCUS

Large complex pleural effusion as the etiology of this patient's
complex pleural effusion ... on Lung POCUS ... your patient has dyspnea ... #POCUS #lung #ultrasound ... #clinical #pulmonary
Diaphragm in Tension Hydrothorax on Lung POCUS

Dyspnea? Wonder why? Where did the lung go...
Tension hydrothorax. Kinda
POCUS Dyspnea ... - VCU Ultrasound ... #POCUS #Effusion ... #pleural #clinical ... #ultrasound #pulmonary
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
with CTD, drugs, malignancy ... Organizing Pneumonia - Clinical ... History: cough, dyspnea ... Rare: pleural effusions ... Pneumonia #COP #BOOP #pulmonary
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
pleural effusion ... Official ATS/STS/STR Clinical ... goals of assessing lung ... #Algorithm #Effusion ... #Pleural #Pulmonary
Nontuberculous Mycobacteria (NTM) Infections 

Mycobacterial species other than those belonging to the Mycobacterium tuberculosis complex and
of right middle lobe ... Hematologic malignancy ... Disease: Clinical ... Weakness, • Dyspnea ... Disease: • Clinical
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
affecting the lungs ... Progression: • Upper lobe ... characteristic features Clinical ... hemoptysis • Dyspnea ... tracheobronchial stenosis, malignancy
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
affecting the lungs ... Progression: • Upper lobe ... characteristic features Clinical ... hemoptysis • Dyspnea ... tracheobronchial stenosis, malignancy